1	Increase	_	NN	_	_	0	ROOT	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	IRF-4	_	NN	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	2	PMOD	_	_
5	in	_	IN	_	_	1	NMOD	_	_
6	hematopoietic	_	JJ	_	_	7	NMOD	_	_
7	cells	_	NNS	_	_	5	PMOD	_	_
8	after	_	IN	_	_	1	NMOD	_	_
9	demethylating	_	NN	_	_	10	NMOD	_	_
10	treatment	_	NN	_	_	8	PMOD	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	next	_	RB	_	_	3	VMOD	_	_
3	analyzed	_	VBD	_	_	0	ROOT	_	_
4	whether	_	IN	_	_	3	VMOD	_	_
5	promoter	_	NN	_	_	6	NMOD	_	_
6	methylation	_	NN	_	_	7	VMOD	_	_
7	could	_	MD	_	_	4	SUB	_	_
8	be	_	VB	_	_	7	VC	_	_
9	responsible	_	JJ	_	_	8	VMOD	_	_
10	for	_	IN	_	_	9	AMOD	_	_
11	down-regulation	_	NN	_	_	10	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	IRF-4	_	NN	_	_	14	NMOD	_	_
14	expression	_	NN	_	_	12	PMOD	_	_
15	.	_	.	_	_	3	P	_	_
		
1	A	_	DT	_	_	2	NMOD	_	_
2	region	_	NN	_	_	9	VMOD	_	_
3	including	_	VBG	_	_	2	APPO	_	_
4	exon1	_	NN	_	_	3	VMOD	_	_
5	in	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	IRF-4	_	NN	_	_	8	NMOD	_	_
8	promoter	_	NN	_	_	5	PMOD	_	_
9	exhibited	_	VBD	_	_	0	ROOT	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	large	_	JJ	_	_	12	NMOD	_	_
12	number	_	NN	_	_	9	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	CpG-rich	_	JJ	_	_	15	NMOD	_	_
15	sequences	_	NNS	_	_	13	PMOD	_	_
16	(	_	(	_	_	18	P	_	_
17	Figure	_	NN	_	_	18	NMOD	_	_
18	3A	_	NN	_	_	15	PRN	_	_
19	)	_	)	_	_	18	P	_	_
20	.	_	.	_	_	9	P	_	_
		
1	Several	_	JJ	_	_	3	NMOD	_	_
2	chemical	_	JJ	_	_	3	NMOD	_	_
3	substances	_	NNS	_	_	15	VMOD	_	_
4	such	_	JJ	_	_	5	DEP	_	_
5	as	_	IN	_	_	3	NMOD	_	_
6	5-aza-2-deoxycytidine	_	NN	_	_	5	PMOD	_	_
7	(	_	(	_	_	8	P	_	_
8	AzadC	_	NN	_	_	6	PRN	_	_
9	)	_	)	_	_	8	P	_	_
10	or	_	CC	_	_	6	COORD	_	_
11	5-azacytidine	_	NN	_	_	10	CONJ	_	_
12	(	_	(	_	_	13	P	_	_
13	AzaC	_	NN	_	_	11	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	inhibit	_	VBP	_	_	0	ROOT	_	_
16	de	_	FW	_	_	17	NMOD	_	_
17	novo	_	FW	_	_	15	VMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	maintenance	_	NN	_	_	20	NMOD	_	_
20	methylation	_	NN	_	_	18	CONJ	_	_
21	,	_	,	_	_	15	P	_	_
22	and	_	CC	_	_	15	COORD	_	_
23	thus	_	RB	_	_	24	VMOD	_	_
24	can	_	MD	_	_	22	CONJ	_	_
25	be	_	VB	_	_	24	VC	_	_
26	used	_	VBN	_	_	25	VC	_	_
27	to	_	TO	_	_	26	VMOD	_	_
28	discern	_	VB	_	_	27	IM	_	_
29	promoter	_	NN	_	_	30	NMOD	_	_
30	methylation	_	NN	_	_	28	VMOD	_	_
31	(	_	(	_	_	32	P	_	_
32	32,33	_	NN	_	_	30	PRN	_	_
33	)	_	)	_	_	32	P	_	_
34	.	_	.	_	_	15	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	used	_	VBD	_	_	0	ROOT	_	_
3	AzadC	_	NN	_	_	2	VMOD	_	_
4	to	_	TO	_	_	2	VMOD	_	_
5	generate	_	VB	_	_	4	IM	_	_
6	unmethylated	_	JJ	_	_	7	NMOD	_	_
7	DNA	_	NN	_	_	5	VMOD	_	_
8	.	_	.	_	_	2	P	_	_
		
1	A	_	DT	_	_	4	NMOD	_	_
2	72	_	CD	_	_	3	AMOD	_	_
3	h	_	NN	_	_	4	NMOD	_	_
4	AzadC-treatment	_	NN	_	_	5	VMOD	_	_
5	resulted	_	VBD	_	_	0	ROOT	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	concentration-dependent	_	JJ	_	_	9	NMOD	_	_
9	activation	_	NN	_	_	6	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	IRF-4	_	NN	_	_	12	NMOD	_	_
12	transcription	_	NN	_	_	10	PMOD	_	_
13	in	_	IN	_	_	9	NMOD	_	_
14	Jurkat	_	NN	_	_	17	NMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	CML-T1	_	NN	_	_	15	CONJ	_	_
17	T-cells	_	NNS	_	_	13	PMOD	_	_
18	as	_	RB	_	_	6	COORD	_	_
19	well	_	RB	_	_	18	DEP	_	_
20	as	_	IN	_	_	18	DEP	_	_
21	in	_	IN	_	_	18	CONJ	_	_
22	U-937	_	NN	_	_	28	NMOD	_	_
23	,	_	,	_	_	22	P	_	_
24	K-562	_	NN	_	_	22	COORD	_	_
25	and	_	CC	_	_	24	COORD	_	_
26	EM-2	_	NN	_	_	25	CONJ	_	_
27	cell	_	NN	_	_	28	NMOD	_	_
28	lines	_	NNS	_	_	21	PMOD	_	_
29	(	_	(	_	_	31	P	_	_
30	Figure	_	NN	_	_	31	NMOD	_	_
31	2A	_	NN	_	_	28	PRN	_	_
32	)	_	)	_	_	31	P	_	_
33	.	_	.	_	_	5	P	_	_
		
1	IRF-4	_	NN	_	_	2	NMOD	_	_
2	transcription	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	induced	_	VBN	_	_	3	VC	_	_
5	in	_	IN	_	_	4	VMOD	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	time-dependent	_	JJ	_	_	8	NMOD	_	_
8	manner	_	NN	_	_	5	PMOD	_	_
9	and	_	CC	_	_	3	COORD	_	_
10	was	_	VBD	_	_	9	CONJ	_	_
11	observed	_	VBN	_	_	10	VC	_	_
12	as	_	RB	_	_	11	VMOD	_	_
13	early	_	RB	_	_	12	AMOD	_	_
14	as	_	IN	_	_	11	VMOD	_	_
15	24	_	CD	_	_	16	NMOD	_	_
16	h	_	NN	_	_	14	PMOD	_	_
17	after	_	IN	_	_	11	VMOD	_	_
18	treatment	_	NN	_	_	17	PMOD	_	_
19	with	_	IN	_	_	18	NMOD	_	_
20	AzadC	_	NN	_	_	19	PMOD	_	_
21	and	_	CC	_	_	10	COORD	_	_
22	increased	_	VBD	_	_	21	CONJ	_	_
23	over	_	IN	_	_	22	VMOD	_	_
24	time	_	NN	_	_	23	PMOD	_	_
25	until	_	IN	_	_	22	VMOD	_	_
26	72	_	CD	_	_	27	NMOD	_	_
27	h	_	NN	_	_	25	PMOD	_	_
28	(	_	(	_	_	30	P	_	_
29	Figure	_	NN	_	_	30	NMOD	_	_
30	2B	_	NN	_	_	27	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	.	_	.	_	_	3	P	_	_
		
1	Time	_	NN	_	_	10	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	strength	_	NN	_	_	2	CONJ	_	_
4	of	_	IN	_	_	1	NMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	appearance	_	NN	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	IRF-4	_	NN	_	_	9	NMOD	_	_
9	transcripts	_	NNS	_	_	7	PMOD	_	_
10	varied	_	VBD	_	_	0	ROOT	_	_
11	among	_	IN	_	_	10	VMOD	_	_
12	cell	_	NN	_	_	13	NMOD	_	_
13	lines	_	NNS	_	_	11	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	i.e.	_	FW	_	_	13	NMOD	_	_
16	CML-T1	_	NN	_	_	15	PMOD	_	_
17	responded	_	VBD	_	_	16	APPO	_	_
18	strongest	_	JJS	_	_	20	AMOD	_	_
19	to	_	TO	_	_	20	AMOD	_	_
20	AzadC-treatment	_	JJ	_	_	17	VMOD	_	_
21	(	_	(	_	_	24	P	_	_
22	data	_	NNS	_	_	24	VMOD	_	_
23	not	_	RB	_	_	24	VMOD	_	_
24	shown	_	VBN	_	_	20	PRN	_	_
25	)	_	)	_	_	24	P	_	_
26	.	_	.	_	_	10	P	_	_
		
1	In	_	IN	_	_	13	VMOD	_	_
2	line	_	NN	_	_	1	PMOD	_	_
3	with	_	IN	_	_	2	NMOD	_	_
4	this	_	DT	_	_	3	PMOD	_	_
5	,	_	,	_	_	13	P	_	_
6	AzadC-treatment	_	NN	_	_	13	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	CML-T1	_	NN	_	_	7	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	LAMA-84	_	NN	_	_	11	NMOD	_	_
11	cells	_	NNS	_	_	9	CONJ	_	_
12	also	_	RB	_	_	13	VMOD	_	_
13	translated	_	VBN	_	_	0	ROOT	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	an	_	DT	_	_	16	NMOD	_	_
16	induction	_	NN	_	_	14	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	IRF-4	_	NN	_	_	20	NMOD	_	_
19	protein	_	NN	_	_	20	NMOD	_	_
20	expression	_	NN	_	_	17	PMOD	_	_
21	(	_	(	_	_	23	P	_	_
22	Figure	_	NN	_	_	23	NMOD	_	_
23	2C	_	NN	_	_	20	PRN	_	_
24	)	_	)	_	_	23	P	_	_
25	.	_	.	_	_	13	P	_	_
		
1	Accordingly	_	RB	_	_	16	VMOD	_	_
2	,	_	,	_	_	16	P	_	_
3	treatment	_	NN	_	_	16	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	IRF-4-positive	_	JJ	_	_	8	NMOD	_	_
7	cell	_	NN	_	_	8	NMOD	_	_
8	line	_	NN	_	_	4	PMOD	_	_
9	BV-173	_	CD	_	_	8	NMOD	_	_
10	,	_	,	_	_	8	P	_	_
11	SD-1	_	NN	_	_	8	APPO	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	RPMI-8226	_	NN	_	_	12	CONJ	_	_
14	with	_	IN	_	_	3	NMOD	_	_
15	AzadC	_	NN	_	_	14	PMOD	_	_
16	had	_	VBD	_	_	0	ROOT	_	_
17	no	_	DT	_	_	18	NMOD	_	_
18	effect	_	NN	_	_	16	VMOD	_	_
19	on	_	IN	_	_	16	VMOD	_	_
20	IRF-4	_	NN	_	_	21	NMOD	_	_
21	expression	_	NN	_	_	19	PMOD	_	_
22	(	_	(	_	_	24	P	_	_
23	Figure	_	NN	_	_	24	NMOD	_	_
24	2D	_	NN	_	_	21	PRN	_	_
25	)	_	)	_	_	24	P	_	_
26	.	_	.	_	_	16	P	_	_
		
1	There	_	EX	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	no	_	DT	_	_	4	NMOD	_	_
4	difference	_	NN	_	_	2	VMOD	_	_
5	in	_	IN	_	_	2	VMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	effects	_	NNS	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	AzaC	_	NNP	_	_	8	PMOD	_	_
10	versus	_	CC	_	_	9	COORD	_	_
11	AzadC	_	NNP	_	_	10	CONJ	_	_
12	,	_	,	_	_	2	P	_	_
13	as	_	IN	_	_	2	VMOD	_	_
14	both	_	DT	_	_	15	VMOD	_	_
15	increased	_	VBD	_	_	13	SUB	_	_
16	the	_	DT	_	_	19	NMOD	_	_
17	IRF-4	_	NN	_	_	19	NMOD	_	_
18	mRNA	_	NN	_	_	19	NMOD	_	_
19	level	_	NN	_	_	15	VMOD	_	_
20	in	_	IN	_	_	19	NMOD	_	_
21	CML-T1	_	NN	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	20	PMOD	_	_
23	as	_	IN	_	_	15	VMOD	_	_
24	well	_	NN	_	_	23	PMOD	_	_
25	(	_	(	_	_	28	P	_	_
26	data	_	NNS	_	_	28	VMOD	_	_
27	not	_	RB	_	_	28	VMOD	_	_
28	shown	_	VBN	_	_	15	PRN	_	_
29	)	_	)	_	_	28	P	_	_
30	.	_	.	_	_	2	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	implied	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	promoter	_	NN	_	_	5	NMOD	_	_
5	methylation	_	NN	_	_	6	VMOD	_	_
6	may	_	MD	_	_	3	SUB	_	_
7	control	_	VB	_	_	6	VC	_	_
8	IRF-4	_	NN	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	7	VMOD	_	_
10	,	_	,	_	_	6	P	_	_
11	but	_	CC	_	_	6	COORD	_	_
12	an	_	DT	_	_	14	NMOD	_	_
13	alternative	_	JJ	_	_	14	NMOD	_	_
14	explanation	_	NN	_	_	15	VMOD	_	_
15	may	_	MD	_	_	11	CONJ	_	_
16	be	_	VB	_	_	15	VC	_	_
17	activation	_	NN	_	_	16	VMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	positive	_	JJ	_	_	21	NMOD	_	_
20	transcriptional	_	JJ	_	_	21	NMOD	_	_
21	regulators	_	NNS	_	_	18	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	IRF-4	_	NN	_	_	22	PMOD	_	_
24	by	_	IN	_	_	17	NMOD	_	_
25	AzadC	_	NNP	_	_	24	PMOD	_	_
26	(	_	(	_	_	25	P	_	_
27	or	_	CC	_	_	25	COORD	_	_
28	AzaC	_	NNP	_	_	27	CONJ	_	_
29	)	_	)	_	_	25	P	_	_
30	.	_	.	_	_	2	P	_	_
		
